SE8201649L - Forfarande for framstellning av prostacyklinderivat - Google Patents

Forfarande for framstellning av prostacyklinderivat

Info

Publication number
SE8201649L
SE8201649L SE8201649A SE8201649A SE8201649L SE 8201649 L SE8201649 L SE 8201649L SE 8201649 A SE8201649 A SE 8201649A SE 8201649 A SE8201649 A SE 8201649A SE 8201649 L SE8201649 L SE 8201649L
Authority
SE
Sweden
Prior art keywords
denotes
ddr
formula
alkyl
carbon atoms
Prior art date
Application number
SE8201649A
Other languages
English (en)
Inventor
N A Nelson
U F Axen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SE8201649L publication Critical patent/SE8201649L/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/10Mercury compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Claims (1)

Pat entkrav
1. FOrfarande fdr framsttllning as en fdrening med formeln dLr R2 betecknar (1) R -C-CgH2I 16 fluoro, kloro, trifluorometyl eller -0R7- dPr R7 betecknar alkyl med 1 - 6 kolatomer, och ddr s betecknar 0, 1, 2 eller 3, varvid hOgst tva T bar annan betydelse On alkyl och ddr ndr s betecknar 2 eller 3 T antingen Pr lika eller olika orb dEr betecknar /••■ H , 63094eller 63014 ddr R3 betecknar vdte eller alkyl med 1 - 4 kolatomer, ddr R4 betecknar vdte, tetrahydropyran-2-yl, tetrahydrofuranyl, 1-etoxietyl eller en grupp med formeln ii 10 0-C R,Rio dal, 16 beteeknar alkyl med 1 - 18 kolatomer, cyklcalkyl mod 3 - kolatomer, aralkyl med 7 - 12 kolatomer, fenyl eller fenyl substituerad med 1, 2 eller 3 alkyl med 1 - 4 kolatomer, dAr 69 och R dr like eller olika, cab betecknar state, alkyl med 1 - 4 kolatomer, fenyl eller fenyl substituerad med 1, 2 eller 3 all, 1 - 4 Ro/r eller ddr 69 ooh Rio tillsag- mans beteckn-(CH2)a- elle_CH2)b-0-(CH2)c- ddr a heteck- nar 3, 4 eller 5, b betecknar 1, 2 eller 3, c betecknar 1, 2 Rd oweller 3 och b plus c betecknar 2, 3 eller 4 och clar Ri, beteck-dar 23 tidigare definierats och dirR har samma betydelse nar 'crate eller fenyl; ddrbetecknarsom R4 med det undantaget att det inte innefattar cite, omvandlas till ett tosylat med formeln ai2 OR ' 4 024 ryCH2CH2-0Ts CH, ddr 01, R,,°oh,/ tidigare definierats och dar Ts betecknar p-to usulfonylgruppen; och eventuellt aylagsnande av den blockerande gruppen R fir bildning an en forening med formeln dar 2, R2, a ach.,, tidigare definierats. , eller ddr R4 tidigare definierats; dar Ts betecknar p-toluensulfonyl- gruppen ochbetecknar anslutning i alfa- eller beta- -kOnfiguration,kannetecknatay att en fire- fling med formeln ddr 22,och,,., tidigare definierats och ddr Qi beteck- oar V's■ HH , 230242 , ei.23OR /0-CH ryCH2C1-12-0H —CH2 C-R, 01
SE8201649A 1976-06-01 1982-03-16 Forfarande for framstellning av prostacyklinderivat SE8201649L (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69139976A 1976-06-01 1976-06-01
US69140076A 1976-06-01 1976-06-01
US78814677A 1977-04-19 1977-04-19
US78814777A 1977-04-19 1977-04-19

Publications (1)

Publication Number Publication Date
SE8201649L true SE8201649L (sv) 1982-03-16

Family

ID=27505431

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7706245A SE436744B (sv) 1976-06-01 1977-05-27 Forfarande for framstellning av prostacyklinderivat
SE7811142A SE432101B (sv) 1976-06-01 1978-10-26 Prostacyklinderivat for anvendning att reglera reproduktionscykeln hos menstruerande hondeggdjur
SE8201649A SE8201649L (sv) 1976-06-01 1982-03-16 Forfarande for framstellning av prostacyklinderivat

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE7706245A SE436744B (sv) 1976-06-01 1977-05-27 Forfarande for framstellning av prostacyklinderivat
SE7811142A SE432101B (sv) 1976-06-01 1978-10-26 Prostacyklinderivat for anvendning att reglera reproduktionscykeln hos menstruerande hondeggdjur

Country Status (13)

Country Link
JP (1) JPS5936912B2 (sv)
AU (1) AU508891B2 (sv)
BE (1) BE855224A (sv)
CA (1) CA1196632A (sv)
CH (1) CH640847A5 (sv)
DE (1) DE2724555A1 (sv)
FR (1) FR2353543B1 (sv)
GB (1) GB1554048A (sv)
IE (1) IE45604B1 (sv)
IL (1) IL52099A (sv)
MX (1) MX4813E (sv)
NL (1) NL7705991A (sv)
SE (3) SE436744B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
FI71138C (fi) 1976-12-31 1986-11-24 Erba Farmitalia Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner
AU524786B2 (en) * 1977-03-07 1982-10-07 The Upjohn Company Prostacyclins
DE2743283A1 (de) * 1977-09-27 1979-04-05 Hoechst Ag Neue prostacyclin-analoga
DE2811950A1 (de) * 1978-03-18 1979-12-13 Hoechst Ag Neue analoga von prostacyclin
US4237060A (en) 1979-03-23 1980-12-02 Hoffmann-La Roche Inc. Prostacyclin analogs
CN1377263A (zh) * 1999-08-05 2002-10-30 帝人株式会社 含有含氮化合物作为活性成分的神经损伤治疗剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1079025B (it) * 1976-05-11 1985-05-08 Wellcome Found Perfezionamento nella preparazione di eteri

Also Published As

Publication number Publication date
CA1196632A (en) 1985-11-12
FR2353543B1 (fr) 1986-02-21
IL52099A (en) 1985-03-31
SE436744B (sv) 1985-01-21
AU508891B2 (en) 1980-04-03
IE45604B1 (en) 1982-10-06
DE2724555A1 (de) 1977-12-15
JPS52156854A (en) 1977-12-27
JPS5936912B2 (ja) 1984-09-06
SE7811142L (sv) 1978-11-28
FR2353543A1 (fr) 1977-12-30
BE855224A (fr) 1977-11-30
AU2508677A (en) 1978-11-16
IL52099A0 (en) 1977-07-31
SE7706245L (sv) 1977-12-16
CH640847A5 (en) 1984-01-31
GB1554048A (en) 1979-10-17
SE432101B (sv) 1984-03-19
MX4813E (es) 1982-10-19
IE45604L (en) 1977-12-01
NL7705991A (nl) 1977-12-05

Similar Documents

Publication Publication Date Title
SE8201649L (sv) Forfarande for framstellning av prostacyklinderivat
ES281419A1 (es) Procedimiento para la detención de derivados de tiaxanteno
GB1305502A (sv)
DK139429B (da) Analogifremgangsmåde til fremstilling af 1-methylpiperidinforbindelser, der i 4-stillingen er substitueret med en dobbeltbundet tricyklisk gruppe.
GB1077673A (en) Triformals
ES424851A1 (es) Un procedimiento para preparar derivados de piperazina.
ES415241A1 (es) Procedimiento para la preparacion de 4-(4-bisenilil)-1-ev- tanol.
ES403486A1 (es) Procedimiento para la preparacion de derivados de piperazi-na.
CH418340A (de) Verfahren zur Herstellung eines neuen Derivats des 1,3-Diazacyclopentens
JPS5334789A (en) Purification of epsilon-caprolactone
ES412047A1 (es) Un procedimiento para la preparacion de dihidrocumarina o una alcohil-dihidrocumarina.
ES364980A1 (es) Un metodo para preparar nuevos derivados de adamantano.
AT249062B (de) Verfahren zur Herstellung von neuen 5-[1'-(Piperidyl-2")-alkyl]-5H-dibenzo[a,d]cyclohepten-5-ol-Derivaten
SU469578A1 (ru) Устройство дл кантовани деталей
IE40887B1 (en) Alkylsulfonylphenoxpropanolamines
JPS52108991A (en) Purification of lactam
ES437041A1 (es) Un procedimiento para preparar derivados de 1-ftalazona.
ES399200A1 (es) Procedimiento de preparacion de nuevos compuestos tetrahi- dropirimidinicos.
SU468926A1 (ru) Способ получени полимеров
SU504255A1 (ru) Секци конденсатора посто нной емкости рулонного типа
AT250945B (de) Verfahren zur Herstellung von neuen 4H-Benzo[4, 5]cyclohepta[1, 2-b] thiophen-Derivaten
ES399271A1 (es) Procedimiento de preparacion de nuevos bromometilatos de n-amino-terciariometil) - 4 - metil - 2 - (trimetoxi-4,6,7- benzofuran-5'-il)-2-dioxolano-1,3.
GB770799A (en) Filter element
JPS5229004A (en) Device for supporting line
ES422825A1 (es) Un metodo de preparar derivados de pteridina.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8201649-4